Logos Global Management LP

Position in CLDX — Celldex Therapeutics, Inc.

CIK 1792126 San Francisco, CA

Position in CLDX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$78,141,000

+$63,867,000 QoQ

Shares Held

2,100,000

+366.7% QoQ

Ownership

2.67%

of shares outstanding

% of Portfolio

3.36%

of 13F equity value

Holder Rank

of 252 holders

Holding Since

Jun 2020

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Logos Global Management LP holds $2,282,084,584 across 63 Biotechnology names. CLDX ranks #9 (3.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ERAS	Erasca, Inc.	12,150,000	$222,588,000
2	ABVX	Abivax S.A.	1,024,000	$136,458,240
3	RVMD	Revolution Medicines, Inc.	700,000	$131,096,000
4	IDYA	IDEAYA Biosciences, Inc.	3,000,000	$111,810,000
5	BNTX	BioNTech SE	1,015,000	$94,445,750
6	VERA	Vera Therapeutics, Inc.	2,200,000	$94,402,000
7	TNGX	Tango Therapeutics, Inc.	2,850,000	$89,091,000
8	PRAX	Praxis Precision Medicines, Inc.	260,000	$87,045,400

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$78,141,000	2,100,000	+366.7%	Shares	Sole	2026-08-14
2026-03-31	$14,274,000	450,000	+28.6%	Shares	Sole	2026-05-15
2025-12-31	$9,506,000	350,000	-41.7%	Shares	Sole	2026-02-17
2025-06-30	$12,210,000	600,000	-33.3%	Shares	Sole	2025-08-14
2024-09-30	$30,591,000	900,000	+38.5%	Shares	Sole	2024-11-14
2024-03-31	$27,280,500	650,000	-45.8%	Shares	Sole	2024-05-15
2020-09-30	$17,796,000	1,200,000	-40.0%	Shares	Sole	2020-11-17
2020-06-30	$26,000,000	2,000,000	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.